Press Releases
November 04, 2024
Developing treatments for people with mental health conditions
October 14, 2024
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare
October 09, 2024
Boehringer Ingelheim collaborates with Circle Pharma
Newsbits
November 05, 2024
Boehringer Advances Oncology Research
September 30, 2024
European Commission approves SPEVIGO® for new and expanded indications in generalized pustular psoriasis
July 30, 2024
Boehringer Ingelheim invests in precision cancer treatments
Stories
World Rabies Day
Rabies? Not in Mexico!
Read how we're helping the authorities keep the country's rabies-free status and our motivations.
Lung Cancer
24 hours in the shoes of a lung cancer patient
The patient experience "A life in a day" aims to deepen our understanding of the challenges faced by those living with severe diseases.
Ruminants
Brazil boosts biosecurity in dairy farms
Learn how we partner with local authorities to enhance best practices through a quality certificate.
Media Contacts
Head of Global Media Relations
E-Mail:
harro.ten_wolde@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-181352
Senior Media Relations Manager
E-Mail:
tereza.urbankova@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-184817
Head of Human Pharma Communications
E-Mail:
anthonia.aboyeji@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-172370
Head of Animal Health Communications
E-Mail:
Heidi.DeWit-Sommerfeld@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-171799
Head of Innovation Unit Communications
E-Mail: camilla.krogh_lauritzen@boehringer-ingelheim.com
Phone Number: +45 2272 4806
Current Events
Past Events
Event
Annual Results Press Conference 2023
